Home / News / New Regulator For Blood Cancer Development Identified

New Regulator For Blood Cancer Development Identified

Wednesday, 23 June, 2021 - 15:39

KL-key research area oncology: A research team led by physicians of the Karl Landsteiner University of Health Sciences in Krems (KL Krems) uncovers a pivotal role for a regulator protein in tumour bone marrow angiogenesis.

Krems, 23th June 2021 – A specific regulatory protein significantly influences the development of tumour-inducing blood vessels in the bone marrow of blood cancer patients. Using a series of different experiments, the team identified that a transcription factor known as JunB is central for the formation of new blood vessels in the bone marrow of patients suffering from multiple myeloma (MM). The findings, which have been published in the journal Leukemia, could pave the way for novel treatment approaches for this still incurable disease.

 

 

Events

  1. 13 Nov

    study INFO DAY

    13. November 2021, 10:00 - 15:00
    Online Event
  2. 02 Jun
  3. 18 May

    ÖH Elections at KL University

    18. May 2021, 11:30 - 20. May 2021, 10:30
    Karl Landsteiner Privatuniversität, Trakt X / Besprechungsraum EG